Medical Marijuana Law
... By the late 1800s, spurred in part by British colonization of India and the resin imported from this new colony, even Queen Victoria of England was known to use hemp for menstrual cramps. Victorian doctors throughout Europe and the United States of America were using Cannabis Indica extracts to treat a variety of illnesses including epilepsy (Association, 1997;Boire & Feeney, 2007). ...
Hemp has a long and complex history with humans—from an essential commodity in the Age of Exploration to widespread prohibition in the 20th century. Recent changes in perception precipitated a renewed interest in this ancient crop. Hemp provides opportunities for environmentally, socially, and economically sustainable agriculture production systems. Each type of hemp crop distinctly contributes to air, soil, and water health. The hemp-derived metabolites and the nutrient-dense grain impact human health. However, the benefits of hemp production come with challenges. Production of hemp for metabolite rapidly expanded during the last decade and quickly resulted in overproduction. The crop continues to face regulatory hurdles, which are exacerbated by industry pushing the boundaries of legality. Despite the challenges, hemp could become a key component of agriculture production around the world.
... 2 U.S. Pharmacopeias in the 19th and early 20th centuries recommended cannabis for many conditions, including alcohol and opiate addiction, neuralgia, and others. 3 This wide range of cannabis-associated symptom management has relevance for patients in the palliative care setting. ...
... Many in the LGBT community believed their plight was being ignored by both the political and medical/pharmaceutical establishment. Some of biggest proponents for medicinal marijuana legalization were activists groups such as ACT UP (Boire and Feeney, 2006). While rooted in AIDS advocacy, these groups had bigger agendas that called for acceptance of the LGBT lifestyle because they believed homophobia was at the heart of the government's tepid response to the epidemic (Christiansen and Hanson, 1996;Gould, 2002). ...
Objective
We examine novel drug use in the lesbian, gay, bisexual, and transgender (LGBT) community in the context of social learning, self‐control, and strain theories.
Methods
Based on a sample of 2,349 college students, we examine novel drug use rates of LGBT participants. We then perform a series of logistic regression models to examine factors correlated with LGBT novel drug use.
Results
We find LGBT individuals have higher rates of use for novel drugs. We find that social learning constructs partially mediate the relationship between sexual orientation and novel drug use. The data did not support the hypotheses that strain or self‐control mediated or acted as a moderator in this relationship.
Conclusion
We hypothesize higher LGBT novel drug use may be related to unique cultural definitions surrounding LGBT drug use and LGBT individuals being less likely to stigmatize substance use. This finding may have implications for LGBT substance use messaging and education programs.
ResearchGate has not been able to resolve any references for this publication.